ABTA's Mind Matters
Patient Care, Research
The National Cancer Institute
Research
Adaptive trial design allows scientists at UCSF, globally to rapidly evaluate more treatments
Patient Care, Research
Scientists know some viral infections can cause cancer later in life. Now, researchers at the UCSF Brain Tumor Center have identified a link between the genetic risk factors for glioma and the immune response to certain common viruses.
Campus News, Research
Biomarker indicates potential treatment strategy with other anti-cancer drugs
Campus News, Research
UCSF News
Campus News, Research
For Reno teenager Olivia Tillis, painting shoes is more than just a hobby – it is a way to honor her mother’s memory, while also giving back to the brain tumor community. Olivia’s mother, Rosie Tillis, was diagnosed with glioblastoma in 2017 and passed away almost two years later.
Patient Stories, Philanthropy
The National Cancer Institute (NCI) has established the Glioblastoma Therapeutics Network (GTN) to support discovery and development of novel therapeutics for glioblastoma. UCSF is among the five teams selected to join the GTN.
Campus News, Research
IBTA's Brain Tumour Magazine
Patient Care
While various immunotherapies work through different mechanisms, they are all designed to enhance the immune system’s ability to recognize and target cancer cells. Pembrolizumab does so by binding and inhibiting PD-1, a protein that normally protects the body from attacking itself.
Patient Care, Research
Marin Magazine
Campus News, Philanthropy
New Advances in Molecular Diagnostics Redefine How Pediatric Brain Tumors are Classified and Treated
The newly released 2021 WHO Classification of Tumors of the Central Nervous System (CNS) introduces major changes that advance the role of molecular profiling in CNS tumor classification and includes ma
Patient Care, Research
UCSF Department of Neurological Surgery
Campus News, Patient Care